Crinetics is a publicly traded, clinical stage, pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. We currently have programs in the areas of acromegaly, neuroendocrine tumors, carcinoid syndrome, Cushing's disease, congenital adrenal hyperplasia, and congenital hyperinsulinism. All programs are the result of internal discovery efforts and these efforts continue to build new programs for entry into our growing pipeline.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):